Acute myeloid leukemia (AML) is an aggressive and heterogeneous hematological malignancy in which treatment resistance and relapse remain major causes of mortality. Extracellular vesicles (EVs) contribute to AML progression by mediating communication among leukemic blasts, leukemia stem cells, hematopoietic stem and pr...
G. Oriquat, Shaker Al-Hasnaawei, Hayjaa Mohaisen Mousa et al.· European Journal of Haematol...· 0 citations
Vaccines that use messenger RNA (mRNA) have become a promising platform that is transforming cancer immunotherapy. These mRNA vaccines can be generated and manufactured quickly due to their modular design and can also induce CD4⁺ T-cell and CD8⁺ T-cell responses, in contrast to conventional protein or peptide-based vac...
Zahraa A. Alkhafaje, M. H., Aniruddh Dash et al.· Current Research in Translat...· 0 citations
Extracellular vesicle (EV)-associated non-coding RNAs (ncRNAs) are increasingly recognized as mediators of intercellular communication within the tumor microenvironment (TME), yet their mechanistic and translational significance varies substantially across gastrointestinal and hepatobiliary cancers. This narrative revi...
T. Alramadneh, Waleed K. Abdulsahib, Sanan Thaer Abdal-Wahab et al.· Cancer Treatment and Researc...· 0 citations
Current evidence on TAM‐driven chemoresistance in GC is synthesized, highlighting the molecular interplay between TAMs, tumor cells, and stromal components and underscores the potential of TAM‐centric therapies to overcome resistance and improve clinical outcomes.
S. Abdul-Rahman, Abdulkareem Shareef, S. Jyothi et al.· Cell Biology International· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
